Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Monday, July 20, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Eyes on Washington: Federal Health Care Grant Notification Service

 

Grant Opportunities for July 6, 2015 through July 17, 2015

 

Visit Holland & Knight online

  

New Federal Health Care Grant Opportunities Announced for:

·         Patient-Centered Outcomes Research Institute (PCORI)

·         US Army Medical Research Acquisition Activity (USAMRAA)

·         National Institutes of Health (NIH)

 

NON-NIH Funding Opportunity Announcements:

 

PCORI: Engagement Award: Knowledge, Training and Development, and Dissemination Awards

The Patient-Centered Outcomes Research Institute (PCORI) will award up to $15.5 million in FY 2015 as part of the Eugene Washington PCORI Engagement Awards program. These awards support projects that encourage active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/clinical effectiveness research (PCOR/CER) enterprise. This funding opportunity was announced July 2, 2015. A letter of intent is due October 1, 2015. The application is due 40 days after review and approval of the letter of intent. For more information, please visit PCORI’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD FY15 Orthotics Outcomes Research Award

Funding Opportunity Number: W81XWH-15-OPORP-OORA

The FY15 Orthotics Outcomes Research Award is intended to support research that evaluates the comparative effectiveness of orthotic clinical interventions and/or their associated rehabilitation interventions, using patient-centric outcomes for Service members and Veterans who have undergone limb impairment or limb amputation. The objective is to improve the understanding of orthotic devices, treatments, rehabilitation strategies, and secondary health effects. The ultimate goal is to advance the adoption and implementation of these evidence-based interventions. Proposed projects should be designed to provide patient-centric outcomes data regarding orthotic devices, and/or related clinical interventions, and must include the anticipated effect on patient care metrics. Principal Investigators (PIs) are strongly encouraged to collaborate, integrate, and/or align their research projects with Department of Defense (DoD) and/or VA research laboratories and programs. All applications must demonstrate direct relevance to Service members and Veterans with traumatic extremity injury and/or amputation using orthotic devices. This funding opportunity was announced July 16, 2015. The application deadline is November 16, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD FY15 Prosthetics Outcomes Research Award

Funding Opportunity Number: W81XWH-15-OPORP-PORA

The FY15 Prosthetics Outcomes Research Award is intended to support research that evaluates the comparative effectiveness of prosthetic clinical interventions, and/or their associated rehabilitation interventions, using patient-centric outcomes for Service members and Veterans who have undergone limb impairment or limb amputation. The objective is to improve the understanding of prosthetic devices, treatments, rehabilitation strategies, and secondary health effects. The ultimate goal is to advance the adoption and implementation of these evidence-based interventions. Proposed projects should be designed to provide patient-centric outcomes data regarding prosthetic devices, and/or related clinical interventions and must include the anticipated effect on patient care metrics. Principal Investigators (PIs) are strongly encouraged to collaborate, integrate, and/or align their research projects with Department of Defense (DoD) and/or VA research laboratories and programs. All applications must demonstrate direct relevance to Service members and Veterans with traumatic extremity injury and/or amputation using prosthetic devices. This funding opportunity was announced July 16, 2015. The application deadline is November 16, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

NIH Funding Opportunity Announcements:

 

NIH: HIV-infected Adolescents: Transitioning from Pediatric to the Adult Care Settings (R21) and (R01)

Funding Opportunity Number: RFA-HD-16-034 and  RFA-HD-16-033

The purpose of this funding opportunity announcement (FOA) is to solicit applications on transition of HIV-infected youth to adult care with the goal of developing an evidence base to support guidelines applicable to low, middle, and high income countries. This initiative is to solicit research on the assessment of programs for the transition of HIV-infected adolescents to the adult healthcare setting both domestically and globally. This area of investigation is neglected, profoundly understudied and of high importance. R21 grants encourage the development of new research activities in categorical program areas. R01 grants support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. These funding opportunities were announced on July 7, 2015. A letter of intent is due December 14, 2015. The application deadline for both R01 and R21 grants is January 14, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcements (R01 and R21).

 

NIH: Secondary Analysis of Existing Databases in Traumatic Brain Injury to Explore Outcomes Relevant to Medical Rehabilitation

Funding Opportunity Number: RFA-HD-16-001

The purpose of this funding opportunity announcement (FOA) is to support secondary analyses of existing databases that have been established from clinical trials, survey studies, or natural histories in traumatic brain injury (TBI). These databases offer opportunities to explore questions about survival, progression, rehabilitation and recovery. This funding opportunity was announced on July 7, 2015. A letter of intent is due September 30, 2015. The application deadline is October 30, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Mechanisms Underlying the Contribution of Type 1 Diabetes Risk Associated Variants (DP3)

Funding Opportunity Number: RFA-DK-15-025

This Funding Opportunity Announcement encourages research project grant applications from institutions/organizations for projects to characterize the genetic variations in human genomic regions that have been putatively associated with type 1 diabetes (T1D) and conduct follow-up functional studies of particular genetic variants. In addition there are many human T1D regions for which there is no compelling functional candidate gene and thus additional work to identify causal genes and potential causal variants and elucidate the mechanisms whereby changes in the function or regulation of these genes are likely to provide crucial new insights into disease pathogenesis are also encouraged. This funding opportunity was announced on July 7, 2015. A letter of intent is due January 17, 2016. The application deadline is February 17, 2016. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Aging Research to Address Health Disparities

Funding Opportunity Number: PA-15-293

The National Institute on Aging's (NIA) Office of Special Populations announces the availability of administrative supplements to support aging research that addresses disparities in health, including preclinical, clinical, social and behavioral studies. NIA is interested in basic research on aging to explore the biological mechanisms through which disparities influence age-related change; in behavioral studies on disparities and aging that investigate environmental, sociocultural and biological influences that delay or accelerate aging health disparities; and in research on geriatric conditions where disparities emerge in diagnosis, prognosis or treatment, including palliative and end-of-life care. This funding opportunity was announced on July 8, 2015. The application deadline is September 17, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

NIH: Limited Competition: Consortia for HIV/AIDS and Alcohol-Related Research Trials (CHAART) Project (Collaborative U01),

Funding Opportunity Number: RFA-AA-16-001

The overall goal of this This Funding Opportunity Announcement (FOA) is to advance operations or implementation research in the context of alcohol and HIV/AIDS 1) to continue to develop a broader systems approach for monitoring complex HIV and alcohol-related morbidity and mortality and 2) to intervene to reduce the impact of alcohol and HIV disease progression and transmission. This proposed research initiative is aligned with the research priorities set forth in the Trans-NIH Plan for HIV-Related Research. The purpose of this FOA is to solicit applications for research projects as part of the consortia on HIV/AIDS and alcohol-related outcomes research. The CHAART Consortium will consist of a cluster of integrated cooperative agreement research projects (U01s) and resource-related research projects (U24s).  The research projects (U01s) will focus on the common theme of HIV/AIDS and alcohol and will have collaborative studies with other U01 projects within the Consortium. The use of common methodology among various research projects and sharing of technical expertise is highly desirable. This funding opportunity was announced on July 8, 2015. A letter of intent is due December 15, 2015. The application deadline is January 15, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Limited Competition: Consortia for HIV/AIDS and Alcohol-Related Research Trials (CHAART) Administrative Resource Core (U24) and Resource Core (U24)

Funding Opportunity Numbers: RFA-AA-16-002 and  RFA-AA-16-003

The overall goal of this Funding Opportunity Announcement (FOA) is to provide administrative support for advancing operations or implementation research in the context of alcohol and HIV/AIDS to 1) continue to develop a broader systems approach for monitoring complex HIV and alcohol-related morbidity and mortality and 2) to intervene to reduce the impact of alcohol and HIV disease progression and transmission. This proposed research initiative is aligned with the research priorities set forth in the Trans-NIH Plan for HIV-Related Research. The CHAART will consist of a cluster of integrated cooperative agreement research projects (U01s) and resource-related research projects (U24s) The research projects (U01s) will focus on the common theme of HIV/AIDS and alcohol and will have collaborative studies with other U01 projects within the Consortium. The use of common methodology among various research projects and sharing of technical expertise are highly desirable. The consortium will include one administrative unit (U24) led by the Consortium Coordinator. The consortium will also include at least two research resources (U24) to provide service to individual research projects (U01). These funding opportunities were announced on July 8, 2015. A letter of intent is due December 15, 2015 for both opportunities. The application deadline for both opportunities is January 15, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcements (Administrative Core and Resource Core).

 

NIH: Claude D. Pepper Older Americans Independence Centers (P30)

Funding Opportunity Number: RFA-AG-16-011

This FOA supports applications for Claude D. Pepper Older Americans Independence Centers (OAICs), centers of excellence in geriatrics research and research education. The OAIC awards are designed to develop or strengthen awardee institutions programs that focus and sustain progress on a key area in aging research. The OAIC awards are designed to develop or strengthen awardee institutions’ programs that focus and sustain progress on a key area in aging research. Each area of focus is one in which progress could contribute to greater independence for older persons and offer opportunities for education in aging research. This funding opportunity was announced on July 9, 2015. A letter of intent is due September 21, 2015. The application deadline is October 21, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Nanomaterials Health Implications Research (NHIR): Comprehensive evaluation of interactions between engineered nanomaterials and biological system (U01)

Funding Opportunity Number: RFA-ES-15-013

This Funding Opportunity Announcement (FOA) seeks applications for research projects as part of NHIR. These research projects will investigate interactions between ENMs and biological systems to generate comprehensive biological response profiles for ENMs that will be provided by Engineered nanomaterials Resource and Coordination Core (ERCC) being solicited through a companion FOA (RFA-ES-15-012). This consortium will generate biological response profiles for a select set of ENMs representing the landscape of nanotechnology applications. The research projects to be funded through this FOA will contribute to long range goals of the NIEHS Nano EHS program, i.e., to derive detailed molecular, biochemical and pathophysiological characterization of ENMs-biological interactions as influenced by physicochemical properties of ENMs. The investigators of the U01 projects as part of the NHIR consortium will carry out investigations on a common set of ENMs, and participate in annual meetings of the consortium coordinated by ERCC. This funding opportunity was announced on July 9, 2015. A letter of intent is due October 30, 2015. The application deadline is November 30, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01), (R03) and (R21)

Funding Opportunity Numbers: PA-15-295 and PA-15-296 and PA-15-294

The objective of this Funding Opportunity Announcement (FOA) is to encourage research on screening and brief interventions to prevent and/or reduce alcohol use and alcohol-related harms among underage and young adult populations. The R01 grant is to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. The R03 grant provides research support specifically limited in time and amount for studies in categorical program areas. The R21 grant is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. These funding opportunities were announced on July 10, 2015. The initial application deadline for R01 is October 5, 2015. The initial deadline for R03 and R21 is October 16, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcements (R01, R03, and R21).  

 

NIH: Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01)

Funding Opportunity Number: RFA-RM-15-009

The Common Fund Program - Accelerating Translation of Glycoscience: Integration and Accessibility - aims to develop accessible and affordable new tools and technologies for studying carbohydrates that will allow biomedical researchers to significantly advance our understanding of the roles of these complex molecules in health and disease. This program will enable investigators who might not otherwise conduct research in the glycosciences, to undertake the study of carbohydrate structure and function. This FOA solicits development of new, more easily accessible tools, reagents, and technologies to facilitate identification, tracking, manipulation, and analysis of glycans with their biological binding partners and determine their functions. This initiative may build on efforts that interface with existing technologies and procedures to make them easier to access and use. As applicable, efforts must consider: factors for scale-up; efforts to make instrumentation broadly accessible and cost-effective for the end-user; and compatibility of data generated with integration into existing databases. This funding opportunity was announced on July 14, 2015. A letter of intent is due September 15, 2015. The application deadline is October 15, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Facile Methods and Technologies for Synthesis of Biomedically Relevant Carbohydrates (U01)

Funding Opportunity Number: RFA-RM-15-007

The Common Fund Program - Accelerating Translation of Glycoscience: Integration and Accessibility - aims to develop accessible and affordable new tools and technologies for studying carbohydrates that will allow biomedical researchers to significantly advance our understanding of the roles of these complex molecules in health and disease. This program will enable investigators who might not otherwise conduct research in the glycosciences, to undertake the study of carbohydrate structure and function. In support of these aims, this FOA is intended to develop new approaches (catalytic methods, chemical/chemo-enzymatic methods, and technologies) to facilitate the rapid, robust, and affordable synthesis, and/or functionalization of bio-medically relevant glycans and glyco-conjugates representing 1) mammalian glycomes and 2) microbial glycans. This funding opportunity was announced on July 14, 2015. A letter of intent is due September 15, 2015. The application deadline is October 15, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)

Funding Opportunity Number: PAR-15-297

This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA. This funding opportunity was announced on July 14, 2015. A letter of intent is due 30 days before the deadline. The initial application deadline is February 17, 2016. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: NINDS Research Program Award (R35)

Funding Opportunity Number: RFA-NS-16-001

The purpose of the NINDS Research Program Award (RPA) is to provide longer-term support and increased flexibility to investigators whose outstanding records of research achievement demonstrate their ability to make major contributions to neuroscience. RPAs will support the overall research programs of NINDS-funded investigators for up to 8 years, at a maximum level of $750,000 direct costs per year. This greater funding stability will provide investigators increased freedom to embark upon research that breaks new ground or extends previous discoveries in new directions. It will also allow Program Directors/Principal Investigators (PDs/PIs) to take greater risks and to undertake research projects that require a longer timeframe. Research supported through the RPA should be within the scope of the NINDS mission. This funding opportunity was announced on July 15 2015. A letter of intent is due September 6, 2015. The application deadline for non-AIDS applicants is October 6, 2015. The deadline for AIDS and AIDS-related applications is January 7, 2016. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Developmental Mechanisms of Human Structural Birth Defects (P01)

Funding Opportunity Number: RFA-HD-16-009

The purpose of this funding opportunity announcement (FOA) is to support innovative, multidisciplinary, interactive, and synergistic program projects (P01s) that integrate basic, translational, and clinical approaches to understanding the developmental biology and genetic basis of significant congenital human malformations. To contain costs, each program project will consist of only three component research projects and associated cores. At least one project must use basic research in an animal model system and at least one project must be clinical or translational in nature. The component research projects must share a common central theme, focus, or objective on a specific major developmental defect or malformation that is genotypically, mechanistically, biologically, or phenotypically analogous or homologous in both animal models and humans. Any non-mammalian or mammalian animal model may be used, as long as it contributes to the common overall theme or objective of the program project. If the component research projects do not share a common developmental gene, process, mechanism, pathway, or phenotype, the application will be considered nonresponsive to this FOA. This funding opportunity was announced on July 15, 2015. A letter of intent is due by October 18, 2015. The application deadline is November 18, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Sickle Cell Disease Implementation Consortium (SCDIC): Using Implementation Science to Optimize Care of Adolescents and Adults with Sickle Cell Disease (U01)

Funding Opportunity Number: RFA-HL-16-010

This Funding Opportunity Announcement (FOA) solicits applications as part of the Sickle Cell Disease Implementation Consortium (SCDIC) to support Clinical Sites to improve the health and well-being of adolescents and adults with sickle cell disease (SCD) in the US through the development of multi-modal, multi-sector interventions aimed at improving the rate at which patients with SCD receive routine primary care. Applications that consist of multi-disciplinary teams of personnel from community and academic health-care institutions are highly sought. This funding opportunity was announced on July 15, 2015. A letter of intent is due by October 12, 2015. The application deadline is November 12, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Data Coordinating Center for Sickle Cell Disease Implementation Consortium (SCDIC): Using Implementation Science to Optimize Care of Adolescents and Adults with Sickle Cell Disease (U24)

Funding Opportunity Number: RFA-HL-16-011

This Funding Opportunity Announcement (FOA) solicits applications for a Data Coordinating Center (DCC), as part of the Sickle Cell Disease Implementation Consortium (SCDIC), to support Clinical Sites that propose to improve the health and well-being of adolescents and adults with sickle cell disease (SCD) in the US through the development of multi-modal, multi-sector interventions aimed at improving the rate at which patients with SCD receive routine primary care (see RFA-HL-16-010). This funding opportunity was announced on July 15, 2015. A letter of intent is due by October 12, 2015. The application deadline is November 12, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Mouse Metabolic Phenotyping Centers Consortium (U2C)

Funding Opportunity Number: RFA-DK-15-010

This Funding Opportunity Announcement invites applications for Mouse Metabolic Phenotyping Centers (MMPC).Member Centers of the MMPC consortium provide fee-for-service in-depth phenotyping tests for mouse models of diabetes, obesity, and related metabolic diseases or conditions.Services are provided with equal priority to investigators inside and outside the home institution, at similar cost.Mice and/or murine tissues can be shipped to MMPC facilities where standardized procedures are used to characterize metabolism, body composition, feeding behavior, physical activity, tissue pathology, brain and other organ function, microbiome, and other physiologic, anatomic or pathologic indices.MMPCs may also provide special mouse models for study at the Center or for distribution, such as mice that have undergone bariatric surgery or are valuable for studying the effects of microbiota on host metabolism. This funding opportunity was announced on July 17, 2015. A letter of intent is due by October 3, 2015. The application deadline is November 3, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.

 

NIH: Coordinating and Bioinformatics Unit for the Mouse Metabolic Phenotyping Centers and the Diabetic Complications Consortium (U24)

Funding Opportunity Number: RFA-DK-15-011

This FOA invites applications from institutions/organizations that propose to provide coordinating and bioinformatics support to be shared by NIDDK's Mouse Metabolic Phenotyping Centers (MMPC) and Diabetic Complications Consortium (DiaComp) programs. The Coordinating and Bioinformatics Unit (CBU) will develop, house and maintain websites and databases, will carry out administrative tasks and organize consortial meetings, and will distribute funds and provide financial management for opportunity pool programs. This funding opportunity was announced on July 17, 2015. A letter of intent is due by October 3, 2015. The application deadline is November 3, 2015. For more information, please visit NIH’s Full Funding Opportunity Announcement.


Association Management Software Powered by YourMembership  ::  Legal